The chart below shows how MVIS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MVIS sees a -0.24% change in stock price 10 days leading up to the earnings, and a -1.88% change 10 days following the report. On the earnings day itself, the stock moves by -0.47%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Industrial Segment Sales Opportunity: Sales in the industrial segment represent the strongest opportunity for us to establish a strong annual recurring revenue stream.
Product Launch Strategy: We expect to start with MOVIA L as our primary hardware product, followed shortly by our MOVIA L safety rated sensor.
Strategic Growth Positioning: We have successfully positioned the company for long-term growth by pursuing significant revenue streams and partnerships from non-automotive industrial channels in the short to medium term.
Cash Burn Reduction Strategy: We have further streamlined our cash burn and extended our runway into 2026, with significantly reduced cash burn and a strong balance sheet.
Balance Sheet Strengthening: We have bolstered our balance sheet as a result of the recently announced convertible note financing, now having a total liquidity of $234 million.
Negative
Q3 Revenue Shortfall: Revenue for Q3 2024 was reported at $0.2 million, which was lower than expectations due to an existing customer pushing out its delivery of sensors from Q3 to Q4.
Sensor Revenue Delay: The expected revenue from the sale of sensors was delayed because the leading agricultural equipment company pushed out their delivery schedule.
R&D and SG&A Expenses: Approximately $15 million of R&D and SG&A expenses were incurred, including $2.4 million of non-cash charges related to stock-based compensation and $1.4 million in non-cash charges related to depreciation and amortization.
Operating Activities Cash Usage: For Q3, $14.1 million cash was used in operating activities, which aligns with previously communicated expectations, but reflects a 25% quarter-over-quarter decrease in cash used.
Projected Operating Expenses: The company anticipates annual OpEx, including R&D and SG&A, to be in the range of $48 million to $50 million for the next year, indicating a significant ongoing cost burden.
MicroVision, Inc. (MVIS) Q3 2024 Earnings Call Transcript
MVIS.O
-5.49%